Who founded Acuamark Dx?

Acuamark Dx was founded by Bernard Peperstraete.

Who are Acuamark Dx's investors?

Acuamark Dx's investors include 1955 Capital.

Acuamark Dx

1 known investors

AcuamarkDx is a molecular diagnostics company developing early cancer detection technology using proprietary qPCR and machine learning-driven assays for cancer screening and recurrence monitoring. It aims to make frequent, recurring cancer signal monitoring a standard part of primary care.

AI & Machine Learning Biotech Digital Health Healthtech Medical Devices

Founders & leadership

Bernard PeperstraeteCo-Founder & CEO

Investors · 1

1955 CapitalSan Francisco · $5M – $10M

Competitors · 1

by search overlap

Naveris4 shared keywordsNaveris is a molecular diagnostics company that develops liquid biopsy blood tests, including its NavDx test, to detect and monitor HPV-driven cancers such as head & neck and anal cancers. Its tests analyze cancer-associated HPV DNA in blood plasma to support earlier detection of recurrence, treatment response assessment, and confirmatory diagnosis for oncology providers and patients.

Companies competing with Acuamark Dx for the same Google search keywords, organic and paid, via search-intersection analysis.

Frequently asked questions

What does Acuamark Dx do?: AcuamarkDx is a molecular diagnostics company developing early cancer detection technology using proprietary qPCR and machine learning-driven assays for cancer screening and recurrence monitoring. It aims to make frequent, recurring cancer signal monitoring a standard part of primary care.
Who founded Acuamark Dx?: Acuamark Dx was founded by Bernard Peperstraete.
Who are Acuamark Dx's investors?: Acuamark Dx's investors include 1955 Capital.